Table 1 Baseline characteristics
T1DM (N = 306) | T2DM (N = 2042) | |
|---|---|---|
Age (years) | 32.7 (11.6) | 58.0 (10.5) |
Median | 30.5 | 58.0 |
Upper quartile, Lower quartile | 39.0, 24.0 | 65.0, 51.0 |
Male/female (%) | 44.1/55.9 | 40.9/59.1 |
Duration of diabetes (years) | 12.1 (8.0) | 12.5 (7.0) |
Median | 10.5 | 11.0 |
Upper quartile, lower quartile | 17.0, 6.0 | 17.0, 7.0 |
Duration of insulin use (years) | 11.2 (7.8) | 6.0 (4.6) |
Median | 10.0 | 5.0 |
Upper quartile, lower quartile | 16.0, 5.0 | 8.0, 3.0 |
HbA1c (mmol/mol) | 67.9 (18.1) | 72.3 (20.4) |
HbA1c (%) | 8.4 (1.7) | 8.8 (1.9) |
FBG (mmol/L) | 8.6 (4.1) | 9.6 (4.0) |
FBG (mg/dL) | 155.0 | 173.0 |
PPG (mmol/L) | 11.1 (4.8) | 12.5 (4.9) |
PPG (mg/dL) | 200.0 (86.5) | 225.2 (88.3) |
Weight (kg) | 70.4 (16.2) | 83.7 (14.9) |
Median | 68.0 | 82.0 |
Upper quartile, lower quartile | 80.0, 60.0 | 92.0, 74.0 |
Height (cm) | 167.8 (10.0) | 164.2 (8.5) |
Median | 168.0 | 164.0 |
Upper quartile, lower quartile | 174.0, 160.0 | 170.0, 158.0 |
BMI (kg/m2) | 25.0 (5.2) | 31.2 (5.7) |
Median | 24.3 | 30.5 |
Upper quartile, lower quartile | 27.2, 21.8 | 34.0, 27.3 |
Previous medical illnesses | % of patients | % of patients |
Neuropathy | 34.6 | 53.1 |
Retinopathy | 20.6 | 39.6 |
Nephropathy | 9.2 | 14.6 |
Peripheral vascular disease | 14.7 | 20.2 |
Angina | 9.8 | 17.4 |
Myocardial infarction | 3.3 | 15.6 |
None | 49.0 | 27.7 |
Symptoms of diabetes-related complications, % | ||
Any | 98.4 | 95.4 |
Tremor | 84.0 | 80.5 |
Sweating | 85.6 | 79.4 |
Hunger | 83.0 | 78.2 |
Tiredness | 83.0 | 76.4 |
Weakness | 78.4 | 72.9 |
Diabetes treatment regimen, % | ||
Short-acting insulin | 12.1 | 5.5 |
Long-acting insulin | 4.6 | 17.3 |
Pre-mix | 4.2 | 33.3 |
Both short- and long-acting | 74.2 | 41.1 |
Both short-acting and pre-mix | 0.3 | 0.6 |
Both long-acting and pre-mix | 3.3 | 1.4 |
Short- and long-acting and pre-mix | 0.0 | 0.0 |
Missing | 1.3 | 0.8 |